A striking example is patients with uveal melanoma another type of melanoma, that is resistant to all immunotherapy regimens, however, a subset of patients, harboring inactivating mutations in methyl-CpG-binding domain protein 4 (MBD4) exhibit sensitivity to ICT [53, 54]. The gene discussed is MBD4; the disease is melanoma.